Akari Therapeutics, Plc
AKTX
$10.73
$1.2112.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -46.80% | 109.46% | -8.37% | 5.00% | -0.65% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 295.14% | -46.99% | -21.92% | -28.71% | 581.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 21.62% | -34.51% | -20.98% | 2.14% | -46.36% |
| Total Current Assets | -34.29% | 85.40% | -10.75% | -1.43% | 13.45% |
|
|
|||||
| Total Current Assets | -34.29% | 85.40% | -10.75% | -1.43% | 13.45% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -10.88% | 0.00% | -13.22% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -29.24% | 5.54% | -10.87% | -0.09% | 0.79% |
|
|
|||||
| Total Accounts Payable | -1.47% | -19.13% | -6.57% | -11.17% | 5.32% |
| Total Accrued Expenses | 42.10% | 44.30% | -34.24% | -29.36% | 11.38% |
| Short-term Debt | -2.92% | -64.38% | 36.85% | -16.20% | -43.37% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 47.22% | -50.71% | -35.09% | -39.36% | 126.04% |
| Total Other Current Liabilities | 47.22% | -50.71% | -35.09% | -39.36% | 126.04% |
| Total Current Liabilities | 8.61% | -20.66% | -9.16% | -18.03% | 5.01% |
|
|
|||||
| Total Current Liabilities | 8.61% | -20.66% | -9.16% | -18.03% | 5.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -2.92% | -64.38% | 36.85% | -16.20% | -43.37% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -15.51% | 1.29% | -12.82% | -1.66% | -1.39% |
| Total Liabilities | -0.28% | -13.77% | -10.34% | -13.37% | 3.11% |
|
|
|||||
| Common Stock & APIC | 0.21% | 1.49% | 1.55% | 2.75% | 1.49% |
| Retained Earnings | -5.46% | -2.04% | -2.53% | -0.76% | -1.50% |
| Treasury Stock & Other | 0.02% | 14.71% | -0.07% | -0.65% | -0.07% |
| Total Common Equity | -49.24% | 24.86% | -11.40% | 17.75% | -2.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.24% | 24.86% | -11.40% | 17.75% | -2.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.24% | 24.86% | -11.40% | 17.75% | -2.17% |
|
|
|||||